Stocksigma LogoStocksigma Logo

Natco Pharma Board to Finalize Terms for ₹1,300 Crore Rights Issue

Natco Pharma Limited announced that its Board of Directors will meet on 25th Sep'26 to determine key terms for its proposed rights issue of up to ₹1,300

Natco Pharma Board to Finalize Terms for ₹1,300 Crore Rights Issue

Natco Pharma Ltd · Intimation · 22 Sept 2026, 11:26 pm

Natco Pharma Board to Finalize Terms for ₹1,300 Crore Rights Issue Natco Pharma Limited announced that its Board of Directors will meet on 25th Sep'26 to determine key terms for its proposed rights issue of up to ₹1,300 crore (face value ₹2 per share), previously approved on 9th Sep'26. The meeting will decide the issue price, payment mechanism, rights entitlement ratio, record date, and issue timing. Consequently, the trading window for designated persons and insiders will remain closed from 23rd Sep'26 until 48 hours post the outcome's disclosure.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements